Stakeholders will have a first opportunity to inform the US Food and Drug Administration’s development of good manufacturing practices for the cosmetics industry at a 1 June virtual “listening session.”
The agency provided additional detail on 26 April after announcing the public meeting two weeks earlier, outlining key topics of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?